Olema Pharmaceuticals, Inc. (OLMA)
13.05
+0.15
(+1.16%)
USD |
NASDAQ |
May 19, 13:10
Olema Pharmaceuticals Research and Development Expense (Quarterly) : 49.23M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 19.02M |
| Protagonist Therapeutics, Inc. | 46.74M |
| Cogent Biosciences, Inc. | 74.21M |
| Disc Medicine, Inc. | 45.82M |
| Nuvalent, Inc. | 83.61M |